secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001654954-23-009002
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin prelim Q4 Vyleesi net revenue $1.7M, up 122% YoY; prescriptions +89% YoY
--------------------------------------------------------------------------------

- Gross product revenue $4.1M, up 20% QoQ and 78% YoY.
- Net product revenue $1.7M, up 42% QoQ and 122% YoY.
- Prescriptions dispensed increased 14% QoQ and 89% YoY.
- New healthcare prescribers up 20% QoQ; 6 consecutive quarters of double-digit growth.
- Management states net revenue per prescription continues to improve, exceeding quarterly operating expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/0001654954-23-009002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423009002/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-009002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer